The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
Reading miRNAs for Clinical Meaning
Single miRNAs Don’t Say Much, but They May Become Eloquent Biomarkers if We Take Their Testimony in Context
Sorting Out the CRISPR Patent Case
Sounds of Science Podcast
For full access to this article login to GEN Select now.
Interview with BIO's James Greenwood
Topics Range from Industry Status to a Preview of May's "BIO 2010" Conference in Chicago
- James Greenwood is president and CEO of the Biotechnology Industry Organization in Washington, D.C. BIO represents more than 1,200 biotechnology companies, academic institutions, state biotech centers, and related organizations across the U.S. and in more than 30 other nations. BIO will hold its annual international conference in Chicago ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.